Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 38
1.
Mol Neurobiol ; 2023 Nov 15.
Article En | MEDLINE | ID: mdl-37964090

The early stages of ageing are a critical time window in which the ability to detect and identify precocious molecular and cognitive markers can make the difference in determining a healthy vs unhealthy course of ageing. Using the 6-different object task (6-DOT), a highly demanding hippocampal-dependent recognition memory task, we classified a population of middle-aged (12-month-old) CD1 male mice in Impaired and Unimpaired based on their short-term memory. This approach led us to identify a different microRNAs expression profile in the hippocampus of Impaired mice compared to Unimpaired ones. Among the dysregulated microRNAs, miR-153-3p was upregulated in the hippocampus of Impaired mice and appeared of high interest for its putative target genes and their possible implication in memory-related synaptic plasticity. We showed that intra-hippocampal injection of the miR-153-3p mimic in adult (3-month-old) mice is sufficient to induce a short-term memory deficit similar to that observed in middle-aged Impaired mice. Overall, these findings unravel a novel role for hippocampal miR-153-3p in modulating short-term memory that could be exploited to prevent early cognitive deficits in ageing.

2.
Article En | MEDLINE | ID: mdl-35691555

Hippocampus erectus inhabiting the shallow coastal waters of the southern Gulf of Mexico are naturally exposed to marked temperature variations occurring in different temporal scales. Under such heterogeneous conditions, a series of physiological and biochemical adjustments take place to restore and maintain homeostasis. This study investigated the molecular mechanisms involved in the response of H. erectus to increased temperature using transcriptome analysis based on RNA-Seq technology. Data was obtained from seahorses after 0.5-h exposure to combinations of different target temperatures (26 °C: control, and increased to 30 and 33 °C) and rates of thermal increase (abrupt: < 5 min; gradual: 1-1.5 °C every 3 h). The transcriptome of seahorses was assembled de novo using Trinity software to obtain 29,211 genes and 30,479 transcripts comprising 27,520,965 assembled bases. Seahorse exposure to both 30 and 33 °C triggered characteristic processes of the cellular stress response, regardless of the rate of thermal change. The transcriptomic profiles of H. erectus suggest an arrest of muscle development processes, the activation of heat shock proteins, and a switch to anaerobic metabolism within the first 0.5 h of exposure to target temperatures to ensure energy supply. Interestingly, apoptotic processes involving caspase were activated principally in gradual treatments, suggesting that prolonged exposure to even sublethal temperatures results in the accumulation of deleterious effects that may eventually terminate in cellular death. Results herein validate 30 °C and 33 °C as potential upper limits of thermal tolerance for H. erectus at the southernmost boundary of its geographic distribution.


Smegmamorpha , Animals , Gene Expression Profiling , Hot Temperature , Smegmamorpha/genetics , Smegmamorpha/metabolism , Temperature , Transcriptome
3.
J Endocrinol Invest ; 44(12): 2845-2847, 2021 Dec.
Article En | MEDLINE | ID: mdl-34037973

PURPOSE: COVID-19 pandemics and cardiometabolic health are mutually interconnected. Chronic metabolic diseases are known risk factors for increased mortality after SARS-CoV-2 infection. In turn, COVID pandemics imposed sudden changes in lifestyle and social isolation with consequent potential cardiometabolic sequelae. The present study aimed at investigating the impact of changes in lifestyle and social life on metabolic profile in hyperprolactinemic or osteoporotic patients without pre-existing cardiometabolic diseases at the time of COVID-19. METHODS: The primary study outcome measurement was the prevalence of obesity, arterial hypertension, impaired glucose tolerance (IGT) or diabetes mellitus (DM), dyslipidemia and metabolic syndrome after COVID-19 outbreak. Seventy-four patients (21 men and 53 women, aged 51.8 ± 17.8 years) were admitted to the outpatient clinic of the Neuroendocrine Disease Unit at University "Federico II" of Naples, Italy, as per their routine clinical practice because of tumoral and non-tumoral hyperprolactinemia in 52 patients (70.3%), and osteoporosis/osteopenia in 22 (29.7%). Among female patients, 25 (47.2%) were at menopausal age. RESULTS: At the end of lockdown, prevalence of obesity (from 37.8% to 51.3%, p < 0.0001), dyslipidemia (from 28.4 to 48.6%, p = 0.003) and metabolic syndrome (from 14.9 to 27%, p < 0.0001) significantly increased compared to pre-COVID evaluation. No significant change was found in the prevalence of arterial hypertension and IGT/DM. CONCLUSION: SARS-CoV-2 outbreak has led to a rapid increase in the prevalence of metabolic syndrome, potentially contributing to the increased COVID-19 related mortality.


COVID-19 , Cardiometabolic Risk Factors , Metabolic Syndrome/epidemiology , Pandemics , Quarantine , Adult , Aged , Aged, 80 and over , Dyslipidemias/epidemiology , Female , Health Status , Humans , Hyperprolactinemia/complications , Italy/epidemiology , Life Style , Male , Middle Aged , Obesity/epidemiology , Osteoporosis/complications , Prevalence , Social Environment
4.
Science ; 355(6328): 966-969, 2017 03 03.
Article En | MEDLINE | ID: mdl-28254944

Indiscriminate activation of opioid receptors provides pain relief but also severe central and intestinal side effects. We hypothesized that exploiting pathological (rather than physiological) conformation dynamics of opioid receptor-ligand interactions might yield ligands without adverse actions. By computer simulations at low pH, a hallmark of injured tissue, we designed an agonist that, because of its low acid dissociation constant, selectively activates peripheral µ-opioid receptors at the source of pain generation. Unlike the conventional opioid fentanyl, this agonist showed pH-sensitive binding, heterotrimeric guanine nucleotide-binding protein (G protein) subunit dissociation by fluorescence resonance energy transfer, and adenosine 3',5'-monophosphate inhibition in vitro. It produced injury-restricted analgesia in rats with different types of inflammatory pain without exhibiting respiratory depression, sedation, constipation, or addiction potential.


Acute Pain/drug therapy , Analgesics, Opioid/chemistry , Analgesics, Opioid/pharmacology , Drug Design , Fentanyl/analogs & derivatives , Piperidines/chemistry , Piperidines/pharmacology , Receptors, Opioid, mu/agonists , Receptors, Opioid, mu/chemistry , Adenosine Monophosphate/antagonists & inhibitors , Analgesia , Analgesics, Opioid/adverse effects , Animals , Computer Simulation , Constipation/chemically induced , Fentanyl/adverse effects , Fluorescence Resonance Energy Transfer , GTP-Binding Protein alpha Subunits/metabolism , HEK293 Cells , Humans , Hydrogen-Ion Concentration , Ligands , Models, Molecular , Pain Management , Piperidines/adverse effects , Protein Binding , Protein Conformation , Rats , Receptors, Opioid, mu/genetics , Respiratory Insufficiency/chemically induced , Transfection
5.
Neurobiol Learn Mem ; 139: 63-68, 2017 Mar.
Article En | MEDLINE | ID: mdl-28039088

MicroRNAs are endogenous, noncoding RNAs crucial for the post-transcriptional regulation of gene expression. In this study, we investigated the role of miR-335-5p in spatial learning and synaptic plasticity. To this end we first showed spatial learning induced down-regulation of miR-335-5p. Next we found impairment in long-term memory and reduction in hippocampal long-term potentiation by exogenous administration of the miRNA. These findings demonstrate that miR-335-5p is a key coordinator of the intracellular pathways that mediate experience-dependent changes in the brain.


Hippocampus/metabolism , MicroRNAs/metabolism , Neuronal Plasticity/genetics , Spatial Learning/physiology , Spatial Memory/physiology , Animals , Hippocampus/drug effects , Male , Memory, Long-Term/drug effects , Memory, Long-Term/physiology , Mice , MicroRNAs/genetics , MicroRNAs/pharmacology , Neuronal Plasticity/drug effects , Spatial Learning/drug effects , Spatial Memory/drug effects
6.
Mol Pharm ; 9(9): 2523-33, 2012 Sep 04.
Article En | MEDLINE | ID: mdl-22827574

Claudin-5 is a tight junction (TJ) protein which limits the diffusion of small hydrophilic molecules. Thus, it represents a potential pharmacological target to improve drug delivery to the tissues protected by claudin-5-dependent barriers. Sodium caprate is known as an absorption enhancer which opens the paracellular space acting on TJ proteins and actin cytoskeleton. Its action on claudin-5 is not understood so far. Epithelial and endothelial systems were used to evaluate the effect of caprate on claudin-5 in TJ-free cells and on claudin-5 fully integrated in TJ. To this aim, confocal microscopy on live and fixed cells and isolated mouse brain capillaries, Western blotting and permeability assays were employed. Caprate reversibly reduced claudin-5 trans-interactions in TJ-free human embryonic kidney-293 cells expressing claudin-5-YFP. It decreased the membranous claudin-5 and the F-actin content in Madin-Darby canine kidney-II cells expressing Flag-claudin-5, thereby increasing the permeability to the small molecule lucifer yellow. Interestingly, zonula occludens protein 1 (ZO-1), which links transmembranous TJ proteins to the actin cytoskeleton, was not affected by caprate treatment. Similarly, endogenous claudin-5 in the membrane of brain endothelia was displaced together with F-actin, whereas ZO-1 remained unaffected. Caprate transiently opens the paracellular space, reducing the intercellular claudin-5/claudin-5 interactions and the polymerized actin at the perijunctional region of endothelial and epithelial cells. In conclusion, the study further elucidates the cellular effects of caprate at the tight junctions.


Claudin-5/metabolism , Decanoic Acids/pharmacology , Endothelial Cells/drug effects , Epithelial Cells/drug effects , Membrane Proteins/metabolism , Tight Junctions/drug effects , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/metabolism , Actins/drug effects , Actins/metabolism , Animals , Brain/drug effects , Brain/metabolism , Capillaries/drug effects , Capillaries/metabolism , Cell Line , Dogs , Endothelial Cells/metabolism , Epithelial Cells/metabolism , HEK293 Cells , Humans , Isoquinolines/metabolism , Madin Darby Canine Kidney Cells , Mice , Mice, Inbred C57BL , Permeability/drug effects , Tight Junctions/metabolism , Zonula Occludens-1 Protein/metabolism
7.
Dev Dyn ; 240(11): 2482-94, 2011 Nov.
Article En | MEDLINE | ID: mdl-22012593

The establishment of rat embryonic stem cells constitutes a precious tool since rat has been extensively used in biomedical research, in particular for the generation of human neurodisease animal models. Up to now only a few studies have described the isolation of rat embryonic stem-like cells. One out of 9 isolated rat embryonic stem-like cell lines (B1-RESC) obtained from a 4.5-day post-coitum blastocyst were extensively characterized and kept in culture for up to 80 passages on feeders with LIF. The stable growth of these cells and the expression of pluripotent markers were confirmed up to a high number of passages in culture, also in the absence of feeders and LIF. B1-RESC expresses the three germ layers markers both in vitro, within differentiating embryoid bodies, and in vivo through teratoma formation. Collectively, the B1-RESC line with a stable near-diploid karyotype can be used as a highly sensitive tool for testing anti-proliferative molecules.


Drug Discovery/methods , Embryonic Stem Cells/cytology , Stem Cell Research , Animals , Cell Differentiation/genetics , Cell Differentiation/physiology , Cell Separation/methods , Cells, Cultured , Embryonic Stem Cells/metabolism , Female , Gene Expression Regulation, Developmental , Mice , Models, Biological , Pregnancy , Rats , Rats, Sprague-Dawley
8.
J Neuroendocrinol ; 23(9): 778-90, 2011 Sep.
Article En | MEDLINE | ID: mdl-21707794

Remyelination failure is a key landmark in chronic progression of multiple sclerosis (MS), the most diffuse demyelinating disease in human, but the reasons for this are still unknown. It has been shown that thyroid hormone administration in the rodent models of acute and chronic demyelinating diseases improved their clinical course, pathology and remyelination. In the present study, we translated this therapeutic attempt to experimental allergic encephalomyelitis (EAE) in the non-human primate Callithrix Jacchus (marmoset). We report that short protocols of triiodothyronine treatment shifts the demyelination/remyelination balance toward remyelination, as assessed by morphology, immunohistochemistry and molecular biology, and improves the clinical course of the disease. We also found that severely ill animals display hypothyroidism and severe alteration of deiodinase and thyroid hormone receptor mRNAs expression in the spinal cord, which was completely corrected by thyroid hormone treatment. We therefore suggest that thyroid hormone treatment improves myelin sheath morphology in marmoset EAE, by correcting the dysfunction of thyroid hormone cellular effectors.


Demyelinating Diseases/drug therapy , Encephalomyelitis, Autoimmune, Experimental , Hypothyroidism/drug therapy , Multiple Sclerosis , Nerve Regeneration/drug effects , Triiodothyronine/therapeutic use , Animals , Biomarkers/metabolism , Callithrix , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/pathology , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Female , Humans , Hypothyroidism/pathology , Hypothyroidism/physiopathology , Male , Multiple Sclerosis/drug therapy , Multiple Sclerosis/pathology , Multiple Sclerosis/physiopathology , Myelin Sheath/pathology , Myelin Sheath/physiology , Myelin Sheath/ultrastructure , Nerve Regeneration/physiology , Oligodendroglia/cytology , Oligodendroglia/physiology , Stem Cells/cytology , Stem Cells/physiology , Thyroid Hormones/metabolism
9.
Neuropediatrics ; 42(2): 55-9, 2011 Feb.
Article En | MEDLINE | ID: mdl-21611938

BACKGROUND: Thromboembolism is a complication of acute lymphoblastic leukemia therapy in children. The majority of thromboembolic events are cerebral thromboses and deep venous thromboses; many asymptomatic deep venous thromboses are detected in children with acute lymphoblastic leukemia by instrumental screening. The aim of this study was to assess the incidence of asymptomatic cerebral thromboembolic events in children with acute lymphoblastic leukemia (ALL) screened by magnetic resonance imaging and magnetic resonance venography. METHODS: 46 children with acute lymphoblastic leukemia, during the induction phase of the AIEOP ALL 2000 protocol, were stratified into 2 groups. In group "A" cerebral thromboembolic events were suspected following the appearance of suggestive signs and symptoms and confirmed by cerebral magnetic resonance imaging and magnetic resonance venography; in group "B" children underwent a screening by cerebral magnetic resonance imaging and magnetic resonance venography, at set times, in absence of symptoms. RESULTS: We observed one cerebral thromboembolic event in both groups; we found no differences between early detecting asymptomatic cerebral thromboembolic events among monitored and not monitored patients. CONCLUSIONS: Our study does not seem to suggest a screening for asymptomatic cerebral thromboembolic events in children with ALL during the induction phase.


Intracranial Thrombosis/diagnosis , Intracranial Thrombosis/etiology , Magnetic Resonance Imaging/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Magnetic Resonance Angiography , Male , Mass Screening/methods , Pilot Projects , Prospective Studies
10.
G Chir ; 32(11-12): 491-4, 2011.
Article En | MEDLINE | ID: mdl-22217379

Most cases of Meckel's diverticulum (MD) are asymptomatic and discovered by chance. Management of MD is controversial. The authors describe an exceptional case of intestinal obstruction caused by a giant MD in a patient who had previously undergone appendectomy. A review of the contradictory literature on this subject leads to the conclusion that careful consideration of clinical and morphological data (patient's age, ASA score, the surgical procedure to be performed, morphology and position of the MD, any fibrotic bands) is required before deciding whether or not to resect an asymptomatic MD.


Ileal Diseases/etiology , Intestinal Obstruction/etiology , Meckel Diverticulum/complications , Abdominal Pain/etiology , Appendectomy , Humans , Ileal Diseases/prevention & control , Ileal Diseases/surgery , Intestinal Obstruction/surgery , Male , Meckel Diverticulum/diagnosis , Meckel Diverticulum/surgery , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Postoperative Complications/surgery , Tissue Adhesions/surgery , Young Adult
11.
J Neurochem ; 115(4): 897-909, 2010 Nov.
Article En | MEDLINE | ID: mdl-20807317

Polychlorinated dibenzo-dioxins, furans and dioxin-like polychlorinated biphenyls are ubiquitous in foodstuffs of animal origin and accumulate in the fatty tissues of animals and humans. The most toxic congener is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a lipophilic endocrine-disrupting molecule that accumulates in adipose tissue, placenta and milk. polychlorinated biphenyls and TCDD are known to interfere with thyroid hormone metabolism and signaling in the developing brain. As thyroid hormone is critical in the myelination process during development, we investigated the effect of a single dose of TCDD prenatal exposure (gestational day 18) on the myelination process. A semi-quantitative analysis of oligodendrocyte markers at different stages of maturation was performed in the offspring's medulla oblongata, cerebellum, diencephalon and telenchephalon at different postnatal days (2/3, 14, 30 and 135). The most significant alterations observed were: (i) cerebellum and medulla oblongata: altered expression of oligodendroglial lineage and platelet-derived growth factor alpha receptor, myelin basic protein (MBP) mRNAs (P2/3, P135) and MBP protein (P135); (ii) diencephalon: increase in platelet- derived growth factor alpha receptor mRNA level (P2/3); (iii) telenchephalon: decrease in MBP mRNA expression. The oligodendroglial generation capability of adult neural stem/precursor cells obtained ex vivo from TCDD and vehicle-treated dams was then explored. TCDD impairs neurosphere proliferation and retards CNPase-positive cell generation from adult neurospheres.


Brain/drug effects , Brain/growth & development , Endocrine Disruptors/administration & dosage , Growth Inhibitors/administration & dosage , Nerve Fibers, Myelinated/drug effects , Polychlorinated Dibenzodioxins/administration & dosage , Prenatal Exposure Delayed Effects/chemically induced , Animals , Animals, Newborn , Brain/pathology , Cell Proliferation/drug effects , Cells, Cultured , Endocrine Disruptors/toxicity , Female , Growth Inhibitors/toxicity , Male , Nerve Fibers, Myelinated/pathology , Oligodendroglia/drug effects , Oligodendroglia/pathology , Polychlorinated Dibenzodioxins/toxicity , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Rats
12.
Neuropathol Appl Neurobiol ; 36(6): 535-50, 2010 Oct.
Article En | MEDLINE | ID: mdl-20609110

AIMS: Neurogenesis in adult humans occurs in at least two areas of the brain, the subventricular zone of the telencephalon and the subgranular layer of the dentate gyrus in the hippocampal formation. We studied dentate gyrus subgranular layer neurogenesis in patients subjected to tailored antero-mesial temporal resection including amygdalohippocampectomy due to pharmacoresistant temporal lobe epilepsy (TLE) using the in vitro neurosphere assay. METHODS: Sixteen patients were enrolled in the study; mesial temporal sclerosis (MTS) was present in eight patients. Neurogenesis was investigated by ex vivo neurosphere expansion in the presence of mitogens (epidermal growth factor + basic fibroblast growth factor) and spontaneous differentiation after mitogen withdrawal. Growth factor synthesis was investigated by qRT-PCR in neurospheres. RESULTS: We demonstrate that in vitro proliferation of cells derived from dentate gyrus of TLE patients is dependent on disease duration. Moreover, the presence of MTS impairs proliferation. As long as in vitro proliferation occurs, neurogenesis is maintained, and cells expressing a mature neurone phenotype (TuJ1, MAP2, GAD) are spontaneously formed after mitogen withdrawal. Finally, formed neurospheres express mRNAs encoding for growth (vascular endothelial growth factor) as well as neurotrophic factors (brain-derived neurotrophic factor, ciliary neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor). CONCLUSION: We demonstrated that residual neurogenesis in the subgranular layer of the dentate gyrus in TLE is dependent on diseases duration and absent in MTS.


Dentate Gyrus/physiopathology , Epilepsy, Temporal Lobe/physiopathology , Neurogenesis/physiology , Neurons/cytology , Adolescent , Adult , Cell Proliferation , Dentate Gyrus/pathology , Epilepsy, Temporal Lobe/pathology , Female , Humans , Immunohistochemistry , Male , Reverse Transcriptase Polymerase Chain Reaction , Sclerosis/pathology
13.
G Chir ; 31(11-12): 511-3, 2010.
Article It | MEDLINE | ID: mdl-21232194

The authors describe a case of giant appendiceal mucocele, secondary to a mucinous neoplasm of the appendix, diagnosed during laparotomy for acute abdomen. By a review of the literature they stress the rarity of this lesion, the particular onset in their case as acute complication of appendiceal neoplasm with rupture of the intestinal wall, the difficulties of diagnosis and management in emergency.


Abdomen, Acute/surgery , Appendiceal Neoplasms/diagnosis , Appendix , Cystadenoma, Mucinous/diagnosis , Laparotomy , Mucocele/pathology , Mucocele/surgery , Abdomen, Acute/etiology , Aged , Appendiceal Neoplasms/complications , Appendiceal Neoplasms/surgery , Appendix/pathology , Appendix/surgery , Body Mass Index , Cystadenoma, Mucinous/complications , Cystadenoma, Mucinous/surgery , Diagnosis, Differential , Female , Humans , Incidental Findings , Mucocele/complications , Mucocele/etiology , Obesity/complications , Risk Factors , Treatment Outcome
14.
J Neurosci Res ; 88(5): 1064-73, 2010 Apr.
Article En | MEDLINE | ID: mdl-19885864

The neuropeptide galanin is a modulator of cholinergic function and may play a role in A beta peptide-induced degeneration of cholinergic forebrain neurons. We have studied the effect of galanin and its galanin receptor subtype 2/3 agonist Gal2-11on toxicity induced by freshly-prepared beta-amyloid(25-35) in the cholinergic cell line SN56. Both nuclear fragmentation and caspase-3 expression were analysed. beta-amyloid(25-35)-exposure induced a significant increase in caspase-3 mRNA expression after 30, 60, 90 or 150 min of beta-amyloid(25-35) exposure. These effects were abolished in the presence of Gal2-11 (10 nM). Similarly, beta-amyloid(25-35)-induced nuclear fragmentation was prevented by the galanin agonist at all time points studied. These findings indicate that the galanin 2/3 agonist Gal2-11 protects SN56 cholinergic cells from beta-amyloid(25-35)-induced cell death and that this action is mediated by an early reduction of caspase-3 expression.


Alzheimer Disease/drug therapy , Amyloid beta-Peptides/antagonists & inhibitors , Galanin/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/pharmacology , Receptor, Galanin, Type 2/agonists , Acetylcholine/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/toxicity , Animals , Apoptosis/drug effects , Apoptosis/physiology , Basal Nucleus of Meynert/drug effects , Basal Nucleus of Meynert/metabolism , Basal Nucleus of Meynert/physiopathology , Caspase 3/genetics , Cell Line, Transformed , Cholinergic Fibers/drug effects , Cholinergic Fibers/metabolism , Cholinergic Fibers/pathology , DNA Fragmentation/drug effects , Galanin/metabolism , Galanin/therapeutic use , Mice , Nerve Degeneration/drug therapy , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Neurons/metabolism , Neuroprotective Agents/metabolism , Neuroprotective Agents/therapeutic use , Peptide Fragments/metabolism , Peptide Fragments/therapeutic use , Peptide Fragments/toxicity , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Receptor, Galanin, Type 2/metabolism , Time Factors
15.
Int J Dev Neurosci ; 27(8): 769-78, 2009 Dec.
Article En | MEDLINE | ID: mdl-19720126

Thyroid hormone exerts a critical role in developmental myelination, acting on the production and maturation of oligodendrocyte, and on the expression of genes encoding for myelin protein. Since remyelination is considered a recapitulation of cellular and molecular events occurring during development, we tested the possibility of stimulating the oligodendroglial lineage and maturation in neurospheres derived from the subventricular zone of adult rats using 3,5,3'-L-triiodothyronine (T3). Both non-pathological and pathological brains derived from rats affected by the inflammatory-demyelinating disease experimental allergic encephalomyelitis (EAE) were included in the study. We investigated the effect of in vitro T3 exposure on: (i) the expression of nuclear thyroid hormone receptors; (ii) proliferation rate; (iii) differentiation into neurons, astrocytes and oligodendrocytes, focusing our attention on oligodendrocyte maturation. T3 reduced the proliferation rate of neurospheres when cultured in the presence of mitogens, shifting towards oligodendroglial lineage as indicated by increased expression of olig-1, and also favoring oligodendrocyte maturation, as indicated by the expression of antigens associated with different maturation stages. Neurospheres derived from EAE rats show a strong limitation in oligodendrocyte generation, which is completely restored by T3 treatment. These results indicate that T3 is a key factor in regulating neurosphere biology, when derived either from non-pathological or pathological adult brains, suggesting that T3 might be an important factor in favoring remyelination in demyelinating disorders.


Myelin Proteins/metabolism , Nerve Regeneration/drug effects , Neuroglia/physiology , Triiodothyronine/pharmacology , Animals , Brain/cytology , Brain/drug effects , Brain/metabolism , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Lineage , Cells, Cultured , Demyelinating Diseases/drug therapy , Demyelinating Diseases/metabolism , Demyelinating Diseases/pathology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Humans , Nerve Regeneration/physiology , Neuroglia/cytology , Rats , Rats, Inbred Lew , Triiodothyronine/metabolism , Triiodothyronine/therapeutic use
16.
Neuropathol Appl Neurobiol ; 34(1): 52-61, 2008 Feb.
Article En | MEDLINE | ID: mdl-17931356

Acute ischaemic brain damages, including both strokes and local ischaemia, are powerful stimulators of neurogenesis in the dentate gyrus of the hippocampus in adult rats and mice. As no data are available in chronic cerebral hypoperfusion, we investigated neurogenesis in rats after bilateral chronic occlusion of the carotid arteries (2VO). 2VO was performed in 3- and 12-month-old rats. Proliferation was investigated by bromodeoxyuridine uptake and MCM2 nuclear immunoreactivity, neurogenesis by counting doublecortin-IR cells in the subgranular area of the dentate gyrus of the hippocampus. We found increased proliferation and neurogenesis in the subgranular area of the dentate gyrus of the hippocampus in adult (3-month-old) rats 8 days after 2VO. This capability is lost in middle-aged (12-month-old) rats. Our data suggest that 2VO ligation can be a useful model for studying neurogenesis in experimental conditions mimicking long-lasting human pathologies, and also in the exploration of the uncertain relation between chronic brain hypoperfusion and age-related changes of cognitive function.


Aging/physiology , Brain Ischemia/physiopathology , Cell Differentiation , Hippocampus/cytology , Neurons/cytology , Animals , Carotid Arteries/surgery , Cell Proliferation , Disease Models, Animal , Doublecortin Protein , Hippocampus/blood supply , Image Processing, Computer-Assisted , Immunohistochemistry , Male , Rats , Rats, Sprague-Dawley , Stem Cells/cytology
17.
Curr Pharm Des ; 12(10): 1221-5, 2006.
Article En | MEDLINE | ID: mdl-16611104

Hereditary hemorrhagic telangiectasia (HHT) or the Rendu-Osler-Weber disease is a systemic fibrovascular autosomal dominant dysplasia, recognised when three of the following four clinical manifestations are present, according to the proposal of Shovlin.: recurrent nosebleeds, lelangiectasias of the skin, visceral lesions, and positive family history. HHT is often difficult to diagnose on the basis of history and physical examination alone, especially in infants and children. The signs and symptoms of HHT are nonspecific and are extremely variable within families. Given the frequent occurrence of clinically silent lesions in lung and brain arteriovenous malformations which can result in morbidity or death, much consideration should be given to screening patients with HHT for asymptomatic fistulae and to their treating once they are discovered. Presymptomatic interventions in such cases may substantially affect the outcome. It may be possible to state that lesions of HHT arise early in life, but do not reach sufficient size to cause symptoms until the second decade. Furthermore, as clinical manifestations often occur later in life, the development and the implementation of a molecular diagnosis will allow the identification of subjects with no evident signs of the disease but carrying the familial mutation. This is fundamental in order to establish reliable screening protocols for the prevention and cure of the disease and, to determine the presence of family members with no disease-associated mutation, who do not require further clinical screening.


Telangiectasia, Hereditary Hemorrhagic/diagnosis , Aging/physiology , Child , Genetic Testing , Humans , Telangiectasia, Hereditary Hemorrhagic/complications , Telangiectasia, Hereditary Hemorrhagic/genetics , Telangiectasia, Hereditary Hemorrhagic/pathology
18.
Ann N Y Acad Sci ; 1054: 40-7, 2005.
Article En | MEDLINE | ID: mdl-16339650

The life expectancy of patients with thalassemia major has significantly increased in recent years, as reported by several groups in different countries. However, complications are still frequent and affect the patients' quality of life. In a recent study from the United Kingdom, it was found that 50% of the patients had died before age 35. At that age, 65% of the patients from an Italian long-term study were still alive. Heart disease is responsible for more than half of the deaths. The prevalence of complications in Italian patients born after 1970 includes heart failure in 7%, hypogonadism in 55%, hypothyroidism in 11%, and diabetes in 6%. Similar data were reported in patients from the United States. In the Italian study, lower ferritin levels were associated with a lower probability of experiencing heart failure and with prolonged survival. Osteoporosis and osteopenia are common and affect virtually all patients. Hepatitis C virus antibodies are present in 85% of multitransfused Italian patients, 23% of patients in the United Kingdom, 35% in the United States, 34% in France, and 21% in India. Hepatocellular carcinoma can complicate the course of hepatitis. A survey of Italian centers has identified 23 such cases in patients with a thalassemia syndrome. In conclusion, rates of survival and complication-free survival continue to improve, due to better treatment strategies. New complications are appearing in long-term survivors. Iron overload of the heart remains the main cause of morbidity and mortality.


beta-Thalassemia/mortality , Adolescent , Adult , Bone Diseases, Metabolic/epidemiology , Bone Diseases, Metabolic/etiology , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/mortality , Cardiomyopathies/etiology , Cardiomyopathies/mortality , Cause of Death , Chelation Therapy , Child , Child, Preschool , Cohort Studies , Diabetes Mellitus/epidemiology , Disease-Free Survival , Female , Ferritins/analysis , Hepatitis C/complications , Hepatitis C/epidemiology , Humans , Hypogonadism/epidemiology , Hypogonadism/etiology , Infant , Infant, Newborn , Iron Overload/etiology , Iron Overload/mortality , Italy/epidemiology , Life Expectancy , Liver Neoplasms/etiology , Liver Neoplasms/mortality , Male , Mortality/trends , Multicenter Studies as Topic , Osteoporosis/epidemiology , Osteoporosis/etiology , Pregnancy , Pregnancy Complications, Hematologic , Prevalence , Transfusion Reaction , beta-Thalassemia/complications , beta-Thalassemia/therapy
19.
Article En | MEDLINE | ID: mdl-16375691

Liver disease is the second cause of mortality in thalassemia major. We present a review on the hepatic damage in thalassemic patients aimed at a knowledge of current preventive, diagnostic and therapeutic approaches, useful to guide in clinical judgment and treatment decisions. Transfusion related iron overload and hepatitis are the causes of liver damage in thalassemic patients. We examined means of primary prevention, anti-hepatitis vaccinations, blood donors screening; diagnostic tests for secondary prevention (computed tomography, magnetic resonance imaging, super conducting quantum interference device and biopsy) were also discussed about. A survey of treatment methods and strategies ( chelation therapy, antiviral treatments and liver and bone marrow transplantation) follows.


Hepatitis, Viral, Human/drug therapy , Iron Overload/drug therapy , Thalassemia/complications , Antiviral Agents/therapeutic use , Hepatitis, Viral, Human/prevention & control , Hepatitis, Viral, Human/virology , Humans , Iron Chelating Agents/therapeutic use , Iron Overload/etiology , Liver Transplantation , Thalassemia/therapy , Transfusion Reaction , Viral Hepatitis Vaccines/therapeutic use
20.
Acta Paediatr ; 93(5): 654-7, 2004 May.
Article En | MEDLINE | ID: mdl-15174790

AIM: To evaluate plasma protein Z (PZ) levels in healthy and high-risk newborn infants. METHODS: A longitudinal observational study was conducted. Inclusion criteria were: healthy term and preterm newborns normal for gestational age and newborns belonging to one of the following groups: newborns small for gestational age (SGA), newborns affected by respiratory distress syndrome (RDS), newborns from mothers with pre-eclampsia. Newborns with sepsis, congenital malformation or haemorrhagic disorders were excluded. Plasma PZ levels, protein C (PC) concentration, PC activity and protein-induced vitamin K absence levels were measured. RESULTS: 53 newborns were enrolled into the study. PZ and PC antigen levels varied significantly among analysed subgroups on day 1 (p < 0.01): lower levels of these inhibitors were found in RDS newborns (group C), newborns from mothers affected by pre-eclampsia (group D) and SGA newborns (group E) than in healthy term and preterm newborns (groups A and B). CONCLUSION: PZ deficiency occurs in newborns affected by severe RDS, in newborns from pre-eclamptic mothers and in SGA newborns, probably owing to activated coagulation in the first two conditions and to reduced PZ synthesis in the last condition.


Blood Proteins/analysis , Respiratory Distress Syndrome, Newborn/blood , Apgar Score , Biomarkers/blood , Birth Weight , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature , Longitudinal Studies , Male , Pre-Eclampsia/complications , Pre-Eclampsia/metabolism , Pregnancy , Protein Precursors/blood , Prothrombin , Risk Factors
...